Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.

Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu C, Zou L, Li Z, Zhao J, Lin N.

FEBS Lett. 2012 Dec 14;586(24):4362-70. doi: 10.1016/j.febslet.2012.10.053. Epub 2012 Nov 21.

2.

Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.

Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.

J Gastroenterol Hepatol. 2011 Nov;26(11):1630-7. doi: 10.1111/j.1440-1746.2011.06758.x.

PMID:
21557766
3.

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J.

Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.

4.

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

Lang Q, Ling C.

Biochem Biophys Res Commun. 2012 Sep 21;426(2):247-52. doi: 10.1016/j.bbrc.2012.08.075. Epub 2012 Aug 23.

PMID:
22940133
5.

MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.

Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J.

Biochem Biophys Res Commun. 2012 Nov 30;428(4):525-31. doi: 10.1016/j.bbrc.2012.10.039. Epub 2012 Oct 12.

PMID:
23068095
6.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W.

Br J Cancer. 2010 Oct 12;103(8):1215-20. doi: 10.1038/sj.bjc.6605895. Epub 2010 Sep 14.

7.

Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.

Wang J, Li J, Wang X, Zheng C, Ma W.

Biochem Biophys Res Commun. 2013 Sep 13;439(1):47-53. doi: 10.1016/j.bbrc.2013.08.032. Epub 2013 Aug 17.

PMID:
23962428
8.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
9.

FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.

Fang F, Yang L, Tao Y, Qin W.

Cancer. 2012 Jan 1;118(1):134-46. doi: 10.1002/cncr.26251. Epub 2011 Jun 28.

10.

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.

Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F.

Liver Int. 2012 May;32(5):752-60. doi: 10.1111/j.1478-3231.2011.02750.x. Epub 2012 Jan 26.

PMID:
22276989
11.

MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.

Yu L, Zhang J, Guo X, Li Z, Zhang P.

Cancer Epidemiol. 2014 Aug;38(4):408-13. doi: 10.1016/j.canep.2014.05.001. Epub 2014 Jun 10.

PMID:
24923856
12.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.

13.

Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H.

Cancer. 2012 May 1;118(9):2431-42. doi: 10.1002/cncr.26566. Epub 2011 Oct 11.

14.

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM.

Cancer Res. 2009 Feb 1;69(3):1135-42. doi: 10.1158/0008-5472.CAN-08-2886. Epub 2009 Jan 20.

15.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

Yang H, Fang F, Chang R, Yang L.

Hepatology. 2013 Jul;58(1):205-17. doi: 10.1002/hep.26315. Epub 2013 May 14.

PMID:
23401231
16.

MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.

Yuan B, Liang Y, Wang D, Luo F.

Cancer Sci. 2015 Jul;106(7):819-24. doi: 10.1111/cas.12688. Epub 2015 May 26.

17.

Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.

Huang B, Li H, Huang L, Luo C, Zhang Y.

J Surg Res. 2015 Feb;193(2):718-23. doi: 10.1016/j.jss.2014.03.076. Epub 2014 Apr 2.

PMID:
25439221
18.

miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.

Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B, Ye Q.

FEBS Lett. 2014 May 21;588(10):1913-20. doi: 10.1016/j.febslet.2014.03.030. Epub 2014 Apr 3.

19.

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.

Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.

Gastroenterology. 2009 Feb;136(2):683-93. doi: 10.1053/j.gastro.2008.10.029. Epub 2008 Nov 1.

PMID:
19027010
20.

Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.

Fan MQ, Huang CB, Gu Y, Xiao Y, Sheng JX, Zhong L.

J Exp Clin Cancer Res. 2013 Apr 18;32(1):21. doi: 10.1186/1756-9966-32-21.

Supplemental Content

Support Center